Linux Foundation hosts RareCamp open-source platform to democratize gene therapy - SiliconANGLE Linux Foundation hosts RareCamp open-source platform to democratize gene therapy - SiliconANGLE CLOUD LINUX FOUNDATION HOSTS RARECAMP OPEN-SOURCE PLATFORM TO DEMOCRATIZE GENE THERAPY by The OpenTreat...

CSL partner says haemophilia drug ‘highly unlikely’ to have cancer link CSL partner says haemophilia drug ‘highly unlikely’ to have cancer link - Companies - Biotech BY CSL has a new ray of hope in its research pipeline, with an experimental haemophilia drug it acquired last year cleared of a...

NEW YORK, March 31, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company") today announced that it will be participating in the Cell & Gene Meeting

LEXINGTON, Mass., March 30, 2021 /PRNewswire/ -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from

Novartis to close Colorado facility, lay off 400 Novartis to close Colorado facility, lay off 400 NOVARTIS TO CLOSE COLORADO FACILITY, LAY OFF 400 Alia Paavola - Thursday, March 25th, 2021 Print | Email Novartis plans to close its gene therapy manufacturing plant in Longmont, Colo., and lay ...

Drugmakers flock to Vineti's fix for a cell, gene therapy problem Drugmakers flock to Vineti's fix for a cell, gene therapy problem DIVE BRIEF: - A coalition of drugmakers has agreed to work with Vineti, a San Francisco-based technology company, to usher in new standards that could ease some of ...

What’s Next For Moderna Post-Covid-19: CEO Stephane Bancel Details mRNA Pipeline What’s Next For Moderna Post-Covid-19: CEO Stephane Bancel Details mRNA Pipeline I t’s been a whirlwind year for Stéphane Bancel. Just over a year ago in March 2020, the World Health Organization declared the Covid-...

Meet the newest grantees of the Bisciotti Foundation Translational Fund Meet the newest grantees of the Bisciotti Foundation Translational Fund By Four Johns Hopkins professors have received grants for their research through the Bisciotti Foundation Translational Fund. Established with a generous...

Click here for updates on this story Toronto, Ontario (CTV Network) — A new gene therapy for an extremely rare disorder has offered two Canadian children a new chance at life, allowing them to move on their own after years of being trapped within their own bodies. The disease is called AADC defic...

HANGZHOU, China, March 22, 2021 /PRNewswire/ -- Innoforce Pharmaceuticals ("INF"), a biopharmaceutical innovation and partnership company, announced today the completion of a 625M CNY ($96M) Series A financing, which follows

Diabetic Dogs Needed for Study that Could Reduce or Eliminate Insulin Injections Diabetic Dogs Needed for Study that Could Reduce or Eliminate Insulin Injections BOONE, Iowa , March 19, 2021 /PRNewswire/ -- Gene therapy company ENDSULIN has expanded to a second study site at Boone Veterinary...

Can you make your brain work harder for you? Can you make your brain work harder for you? - Mindfulness BY It has taken the chaos of two kids under three, chronically egg-stained clothes, zero personal space and returning to work to appreciate Eckhart Tolle’s message of mindful presence. That i...

Clinical Trial Begins For Gene Therapy To Treat Alzheimer’s Disease Clinical Trial Begins For Gene Therapy To Treat Alzheimer’s Disease Researchers at the University of California, San Diego have launched a clinical trial of a gene therapy for patients with Alzheimer’s disease. The treatment deli...

Gene Therapy for Sickle Cell Did Not Cause Patient's Leukemia Gene Therapy for Sickle Cell Did Not Cause Patient's Leukemia March 11, 2021 GENE THERAPY FOR SICKLE CELL DID NOT CAUSE PATIENT'S LEUKEMIA Bluebird Bio says it has not found evidence that its gene therapy caused the sickle cell patien...

A new study found that the cells that drive myelin repair become less efficient as we age and identified a key gene that is most affected by aging, which reduces the cells’ ability to replace lost myelin.

MUNICH, March 11, 2021 /PRNewswire-PRWeb/ -- SIRION Biotech GmbH, a world leader in viral vector-based gene delivery technologies for gene & cell therapy, is hosting a webinar titled "Engineering AAV

The UK’s National Health Service Just Approved a Drug That Costs Nearly $2.5 Million a Dose – NBC Bay Area The UK’s National Health Service Just Approved a Drug That Costs Nearly $2.5 Million a Dose – NBC Bay Area - The innovative gene therapy, called Zolgensma, has a reported list price of £1.7...